Skip to main content
Sinopharm Tech Holdings Limited logo

Sinopharm Tech Holdings Limited — Investor Relations & Filings

Ticker · 8156 ISIN · KYG2159V1418 HKEX Wholesale and retail trade
Open in API
Filings indexed 1,471 across all filing types
Latest filing 2020-05-06 Regulatory Filings
Country HK Hong Kong
Listing HKEX 8156

About Sinopharm Tech Holdings Limited

http://www.sinopharmtech.com.hk

Sinopharm Tech Holdings Limited is an investment holding company primarily engaged in the big health industry and pharmaceutical supply chain business. The company focuses on the trading and distribution of medical and related products, including Chinese patent medicines and health products, targeting the market in the PRC. It develops its supply chain operations using "Internet Plus" services, leveraging technology to provide value-added services to industry operators and product suppliers. The Group is also integrating AI analytics to enhance its operations within the healthcare sector.

Recent filings

Filing Released Lang Actions
DELAY IN DESPATCH OF CIRCULAR
Regulatory Filings Classification · 95% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding a delay in the dispatch of a circular related to a subscription agreement and connected transaction. It references a previous announcement and states that the circular, which includes detailed information and notices for an Extraordinary General Meeting (EGM), will be delayed. The document is short (3045 characters) and serves as a notification about the timing of a report (the circular) rather than containing the report itself or substantive financial data. It does not contain financial statements, audit information, or detailed management discussion. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement about procedural timing rather than a full report or financial disclosure.
2020-05-06 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2020
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions for the month ended 30/04/2020. The content focuses on share capital changes, share options, warrants, and convertible bonds, which are typical disclosures related to share capital changes and equity movements. There is no indication of financial performance data, management discussion, earnings, or audit information. The document is a regulatory filing reporting monthly movements in securities and share capital, consistent with a Share Issue/Capital Change announcement. It is not a full report but a regulatory disclosure of capital changes.
2020-05-04 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding the date of a board meeting to approve the unaudited consolidated results for the nine months ended 31 March 2020 and to consider dividend payment. It does not contain the actual financial results or detailed financial data but rather informs about the upcoming board meeting where such results will be approved and published. The document is short (2389 characters) and serves as a notice rather than a full financial report. According to the 'MENU VS MEAL' rule, this is an announcement about a report, not the report itself. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2020-05-04 English
VOLUNTARY ANNOUNCEMENT IN RELATION TO A FRAMEWORK COOPERATION AGREEMENT WITH A WHOLLY-OWNED SUBSIDIARY OF TENCENT HOLDINGS
Capital/Financing Update Classification · 85% confidence The document is a voluntary announcement by Sinopharm Tech Holdings Limited regarding a new strategic cooperation agreement with a subsidiary of Tencent Holdings. It is an announcement informing shareholders and potential investors about a business development, specifically a framework cooperation agreement in the medical supplies and services field. The document does not contain financial statements, audit information, voting results, or any detailed report data. It is not a report publication announcement since it is not about the release of a report but about a business cooperation agreement. The document is also not a regulatory filing or certification. Given the content, this fits best under Capital/Financing Update (CAP) as it relates to a strategic business cooperation that could impact the company's capital or business operations, although it is voluntary and not a fundraising announcement per se, it is the closest relevant category among the options provided.
2020-04-06 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2020
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/03/2020, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content is focused on share capital changes and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting monthly share capital movements to the exchange, consistent with regulatory compliance disclosures. The document is lengthy (15,000 characters) and contains detailed data, not just an announcement or certification. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about share capital movements that does not fit other more specific categories like Share Issue/Capital Change (SHA) because it is a monthly return report rather than a single event announcement.
2020-04-06 English
CONNECTED TRANSACTIONS INVOLVING ALLOTMENT AND ISSUE OF NEW SHARES UNDER SPECIFIC MANDATE
Capital/Financing Update Classification · 95% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding the allotment and issue of new shares under a specific mandate. It details a subscription agreement for new shares, the subscription price, conditions precedent, use of proceeds, and implications under listing rules. The content focuses on a capital raising transaction involving new share issuance and connected transactions. It is not a full financial report, earnings release, or management discussion, but rather a detailed update on financing activity and share capital changes. Therefore, it fits the category of Capital/Financing Update (CAP). The document length and detail confirm it is not a brief announcement or a simple notice, but a substantive update on financing.
2020-04-03 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.